Evidence map›Paper›PMID 26019553›Full record

ArticleBiotechnology, biotechnological equipment2014

Protective effects of ethyl pyruvate in cisplatin-induced nephrotoxicity.

Ilker Kelle, Hasan Akkoc, Selcuk Tunik, Yusuf Nergiz, Meral Erdinc, Levent Erdinc

Open access · goldAbstract read
In one paragraph

Article in Biotechnology, biotechnological equipment, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Ethyl pyruvate, a versatile protector in inflammation and autoimmunity.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2022
    Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Ilker KelleDepartment of Pharmacology, School of Medicine, Dicle University , Diyarbakir , Turkey.
Hasan AkkocDepartment of Pharmacology, School of Medicine, Dicle University , Diyarbakir , Turkey.
Selcuk TunikDepartment of Histology and Embryology, School of Medicine, Dicle University , Diyarbakir , Turkey.
Yusuf NergizDepartment of Histology and Embryology, School of Medicine, Dicle University , Diyarbakir , Turkey.
Meral ErdincDepartment of Pharmacology, School of Medicine, Dicle University , Diyarbakir , Turkey.
Levent ErdincDepartment of Biochemistry, School of Medicine, Dicle University , Diyarbakir , Turkey.
Dicle University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study was performed to investigate the effect of ethyl pyruvate on changes in renal functions and oxidative stress related renal injury caused by cisplatin (cis-dichlorodiammine platinum-II; CDDP). Male Wistar albino rats were divided into four groups (

Indexed as

cisplatinethyl pyruvatenephrotoxicityoxidative stress index (OSI)rattotal antioxidant status (TAS)total oxidant status (TOS)

Identifiers

PMID26019553
PMCPMC4433950
OpenAlexW1979678462

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.